The North America pharmaceutical continuous manufacturing market is set to project a CAGR of 9.95% during the forecast period, 2021-2028. The surging use of continuous manufacturing systems and the presence of well-developed infrastructure in pharmaceutical industries are projected to propel market growth.
NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028
North America Pharmaceutical Continuous Manufacturing Market by Product (Integrated Continuous System, Semi-continuous System, Control & Software) by Application (Final Drug Product Manufacturing, Api Manufacturing) by End-user (Pharmaceutical Companies, Contract Manufacturing Organizations, Other End-users) and by Geography
The North America pharmaceutical continuous manufacturing market is set to project a CAGR of 9.95% during the forecast period, 2021-2028. The surging use of continuous manufacturing systems and the presence of well-developed infrastructure in pharmaceutical industries are projected to propel market growth.
To know more about this report, request a free sample copy
Canada and the United States are analyzed for the North America pharmaceutical continuous manufacturing market growth assessment. Half of the world’s R&D activities for pharmaceuticals are conducted by US-based firms as per the Pharmaceutical Research and Manufacturers Association (PhRMA). Several initiatives by the government agencies to supplement the use of continuous manufacturing concepts are beneficial to market growth. For instance, the pharma organizations are encouraged by the US FDA (Food and Drug Administration) to incorporate continuous manufacturing concepts. The United States also has the presence of key players, which further supports the market growth. Moreover, the free pricing policy is a major benefit to the industry. Such factors are expected to facilitate market growth.
Eli Lilly and Company is a pharmaceutical company that manufactures, discovers, develops, and sells pharmaceutical products and animal health products. It supplies human pharmaceutical products in the therapeutic areas of endocrinology, cardiovascular, immunology, oncology, and neuroscience. It supplies its products to physicians, hospitals, and pharmacies. It has a business presence in the United States, Europe, Japan, etc. The company has its headquarters in Indianapolis, Indiana, the US.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- INCREASED ADOPTION OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS
- RISING GOVERNMENT INITIATIVES FOR THE ADOPTION OF CONTINUOUS MANUFACTURING SYSTEMS
- RISE IN PRODUCTION OF LARGE MOLECULES AND BIOLOGICS
- INCREASE IN HEALTHCARE EXPENDITURE
- KEY RESTRAINTS
- INCREASING CUSTOMER ANTICIPATIONS
- KEY DRIVERS
- KEY ANALYTICS
- PORTER’S FIVE FORCE ANALYSIS
- THREAT OF NEW ENTRY
- THREAT OF SUBSTITUTION
- BUYER’S POWER
- SUPPLIER’S POWER
- COMPETITIVE RIVALRY
- IMPACT OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
- REGULATORY FRAMEWORK
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- KEY INVESTMENT INSIGHTS
- PORTER’S FIVE FORCE ANALYSIS
- MARKET BY PRODUCT
- INTEGRATED CONTINUOUS SYSTEM
- SEMI-CONTINUOUS SYSTEM
- CONTROL & SOFTWARE
- MARKET BY APPLICATION
- FINAL DRUG PRODUCT MANUFACTURING
- API MANUFACTURING
- MARKET BY END-USER
- PHARMACEUTICAL COMPANIES
- CONTRACT MANUFACTURING ORGANIZATIONS
- OTHER END-USERS
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGER & ACQUISITIONS
- PRODUCT LAUNCH & DEVELOPMENTS
- PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
- BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
- COMPANY PROFILE
- COPERION GMBH
- ELI LILLY & COMPANY
- GEA GROUP AG
- GEBRUDER LODIGE MASCHINENBAU GMBH
- GLATT GMBH
- HOSOKAWA MICRON CORPORATION
- KORSCH AG
- LB BOHLE MASCHINEN + VERFAHREN GMBH
- MUNSON MACHINERY COMPANY
- PFIZER INC
- SIEMENS HEALTHINEERS
- SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)
- THERMO FISHER SCIENTIFIC INC
- KEY STRATEGIC DEVELOPMENTS
TABLE LIST
TABLE 1: MARKET SNAPSHOT – PHARMACEUTICAL CONTINUOUS MANUFACTURING
TABLE 2: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: LEADING PLAYERS OPERATING IN NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
FIGURE LIST
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: OPPORTUNITY MATRIX
FIGURE 3: VENDOR LANDSCAPE
FIGURE 4: KEY INVESTMENT INSIGHTS
FIGURE 5: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, IN 2020
FIGURE 6: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, IN 2020
FIGURE 10: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, IN 2020
FIGURE 13: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 17: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)
FIGURE 18: CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET BY PRODUCT
- INTEGRATED CONTINUOUS SYSTEM
- SEMI-CONTINUOUS SYSTEM
- CONTROL & SOFTWARE
- MARKET BY APPLICATION
- FINAL DRUG PRODUCT MANUFACTURING
- API MANUFACTURING
- MARKET BY END-USER
- PHARMACEUTICAL COMPANIES
- CONTRACT MANUFACTURING ORGANIZATIONS
- OTHER END-USERS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.